Index
ORIGINAL PUBLICATIONS; 1995 to 2004
-
117. Furihata K, Kato K,
Kanaji S, Rhadis-Baptista G, Kunicki TJ.
2004. Characterization of a soluble, recombinant convulxin that is an
effective platelet agonist. Submitted.
Medline ID = Unavailable
-
116.
Kunicki TJ, Salomon DR, Nakagawa P,
Crisler P, Harrison P, Nugent D. 2004. Genetic predilection for
aspirin-resistance in normal, healthy subjects and patients with ischemic
coronary disease. Submitted.
Medline ID = Unavailable
-
115.
Kanaji S, Jacquelin B, Chang M, Nugent DJ, Kunicki TJ. 2004.
Transcriptional Regulation of Collagen Receptor
Genes ITGA1and GP6 during Megakaryocyte Differentiation
by CpG Methylation. Submitted.
Medline ID = Unavailable
-
114.
Kunicki TJ, Salomon DR, Koziol J, Head S,
Mondala T, Chismar JD, Baronciani L, Canciani MT, Federici AB. 2004. An
association of integrin gene haplotypes and bleedingseverity in Von Willebrand Disease (VWD) type 1 pedigrees. Blood, Accepted.
E-Publication.
Medline ID =
15226188
-
113. Nurden P, Jandrot-Perrus M, Combrie R,
Winckler J, Arocas V, Lecut C, Pasquet JM, Kunicki TJ, Nurden AT. 2004.
Severe deficiency of glycoprotein VI in a patient with gray platelet
syndrome. Blood, 104(1):107-14.
Medline ID =
15010364
-
112. Vasudevan S, Celikel R, Ruggeri ZM,
Varughese KI, Kunicki TJ. 2004. A single amino acid change in the binding
pocket alters specificity of an anti-integrin antibody AP7.4 as revealed by its
crystal structure. Blood Cells and Molecular Disease, 32(1):176-81.
Medline ID =
14757433
-
111. Kanaji
S, Kanaji T, Furihata K, Ware JL, Kunicki TJ. 2003. Convulxin binds to
native, human glycoprotein Ib (GPIb.
J Biol Chem, 278(41):39452-60.)
Medline ID =
12881531
-
110. Kato K, Kanaji T, Russell S,
Kunicki TJ,
Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. 2003. The
contribution of glycoprotein VI to stable platelet adhesion and thrombus
formation illustrated by targeted gene deletion. Blood, 102(5):1701-1707.
Medline ID =
12738669
-
109. Jacquelin B, Tuleja E,
Kunicki TJ, Nurden
P, Nurden AT. 2003. Analysis of platelet membrane glycoprotein polymorphisms
in Glanzmann thrombasthenia showed the French gypsy mutation in the alpha IIb
gene to be strongly linked to the HPA-1b polymorphism in beta3. J Thromb
Haemost., 1(3):573-575.
Medline ID =
12871468
-
108. Furihata K,
Kunicki TJ. 2002.
Characterization of the human GPVI gene (GP6) 5’-regulatory and promoter
regions. Arterioscler Thromb Vasc Biol., 22(10):1733-1739.
Medline ID =
12377757
-
107. Nurden AT, Ruan J, Pasquet J-M, Gauthier
B, Combrié R, Kunicki T, Nurden P. 2002. A novel 196Leu to Pro
substitution in the β3 subunit of the αIIbβ3 integrin in a patient with a
variant form of Glanzmann thrombasthenia. Platelets, 13:101-111.
Medline ID =
11897046
-
106. Furihata K, Clemetson K, Deguchi H, and
Kunicki TJ. 2001. Variation
in human platelet GPVI content modulates GPVI-specific prothrombinase
activity. Arterioscler Thromb Vasc Biol., 21(11):1857-1863.
Medline ID =
11701478
-
105. Jacquelin
B, Rozenshteyn D, Kanaji S, Koziol JA, Nurden AT and Kunicki TJ. 2001.
Characterization of inherited differences in transcription of the human
integrin α2 gene. J. Biol. Chem., 276(26):23518-235243.
Medline ID =
11313353
-
104. Jacquelin B, Tarantino MD, Kritzik M,
Rozenshteyn D, Koziol JA, Nurden AT and Kunicki TJ. 2001. Allele-dependent
transcriptional regulation of the human integrin α2 gene. Blood,
97(6):1721-1726.
Medline ID =
11238113
-
103. Di Paola J, Federici AB, Sacchi E,
Canciani MT, Mannucci PM, Kritzik M, Kunicki TJ and Nugent DJ. 1999 Low
platelet α2β1 levels in patients with von Willebrand
Disease Type I represent an increased risk factor for bleeding. Blood,
93(11):3578-3582.
Medline ID =
10339461
-
102. Santoso S,
Kunicki TJ, Kroll H,
Haberbosch W and Gardemann A. 1999. Association of the platelet
glycoprotein Ia C807T gene polymorphism with myocardial infarction
in younger patients.Blood, 93(8):2449-2453.
Medline ID =
10194421
-
101. Tomiyama Y, Shiraga M, Kinoshita
S, Ambo H, Kurata Y, Matsuzawa Y and Kuncki TJ. 1998.
A Glanzmann thrombasthenia-like
phenotype caused by a defect in inside-out signaling through the integrin
αIIbβ3. Thromb. Haemost., 80:735-742.
Medline ID =
99057298
- 100.
Kodandapani R, Veerapandian L, Ni C-Z, Chiou C-K, Whital R,
Kunicki TJ and Ely KR. 1998. Conformational
change in an anti-integrin antibody: Structure of OPG2 Fab bound to a
b3
peptide. Biochem. Biophys. Res. Comm. 251:61-6.
Medline ID =
99009222
- 99.
Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM and
Kunicki TJ. 1998 Nucleotide polymorphisms in
the a2
gene define multiple alleles which are associated with differences in platelet
a2b1.
Blood, 92:2382-2388.
Medline ID =
98421383
- 98.
Brojer E, Ambo H, and Kunicki TJ. 1997.
Expression of the murine antibody AP2 specific for the integrin
aIIbb3
complex with the use of bacteriophage lambda vectors. Central European J.
Immunol., 22:225-231.
Medline ID = Unavailable
- 97.
Kunicki TJ, Felding-Haberman B and Annis DS.
1997. Molecular determinants of RGD ligand specificity for
b3
integrins. J.Biol.Chem.,272:4103-4107.
Medline ID =
97172476
- 96.
Kunicki TJ, Kritzik M, Annis DS and Nugent DJ.
1997. Hereditary variation in platelet integrin
a2b1
density is associated with two silent polymorphisms in the
a2
gene coding sequence. Blood, 89(6):1939-1943.
Medline ID =
97211747
- 95.
Humbert M, Nurden P, Bihour C, Pasquet J-M, Winckler J, Heilmann E, Savi P,
Herbert J-M, Kunicki TJ and Nurden AT. 1996.
Ultrastructural studies of platelet aggregates from human subjects receiving
clopidogrel and from a patient with an inherited defect of an ADP-dependent
pathway of platelet activation. Arteriosclerosis, 16:1532-1543.
Medline ID =
97132002
- 94.
McKay BS, Annis DS, Honda S, Christie D and Kunicki
TJ. 1996. Molecular requirements for assembly and function of a
minimized human integrin
aIIbb3.
J.Biol.Chem.,271:30544-30547.
Medline ID =
97094790
- 93.
Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ
and Niewarowski S. 1996. Immunological characterization of eristostatin and
echistatin binding sites on
aIIbb3
and aVb3
integrins. Biochemical Journal, 317:817-825.
Medline ID =
96332475
- 92.
Kunicki TJ, Annis DS, Deng YJ, Loftus JC and
Shattil SJ. 1996. A molecular basis for affinity modulation of Fab ligand
binding to the integrin
aIIbb3
J.Biol.Chem., 271:20315-20321.
Medline ID =
96355355
- 91.
Humbert M, Kunicki TJ, Bihour C, Winckler J,
Nurden AT and Nurden P. 1996. Visualization of activation-dependent epitopes
on glycoprotein IIb-IIIa complexes of platelets stimulated by thrombin:
Immunogold staining of ultrathin sections. Sem. Thromb. Hemost., 22:279-288.
Medline ID =
96432986
- 90.
Nurden P, Humbert M, Piotrowicz RS, Bihour C, Nurden AT and
Kunicki TJ. 1996. The distribution of
ligand-occupied aIIbb3
in resting and activated human platelets determined by expression of a novel
class of ligand-induced binding site (LIBS) recognized by monoclonal antibody
AP6. Blood, 88:887-899.
Medline ID =
96309632
- 89.
Schneppenheim R, Brassard J, Krey S, Budde U, Kunicki
TJ, Holmberg L, Ware J and Ruggeri ZM. 1996. Defective dimerization of
von Willebrand Factor subunits due to a Cys to Arg mutation in Type IID von
Willebrand Disease. Pro. Natl. Acad. Sci. U.S.A., 93:3581-3586.
Medline ID =
96195014
- 88.
Pelletier AJ, Kunicki TJ and Quaranta V. 1996.
Activation of the integrin
aVb3
involves a discrete cation-binding site that regulates conformation. J. Biol.
Chem., 271:1364-1370.
Medline ID =
8576125
- 87.
Gruel Y, Nugent DJ, Kunicki TJ. 1995.
Molecular specificity of anti IIb/IIIa human antibodies. Sem. Thromb. Hemost.,
21(1):60-67.
Medline ID =
95327967
- 86.
Kunicki TJ, Ely KR, Kunicki T.C., Annis DS.
1995. The exchange of Arg-Gly-Asp (RGD) and Arg-Tyr-Asp (RYD) binding
sequences in a recombinant murine Fab fragment specific for the integrin
aIIbb3
does not alter integrin recognition. J. Biol. Chem., 270(28): 16660-16665.
Medline ID =
95348086
- 85.
Ely KR, Kunicki TJ, Kodandapani R. 1995 Common
molecular scaffold for two unrelated RGD molecules. Protein Engineering,
8:823-827.
Medline ID =
96227676
- 84.
Pelletier AJ, Kunicki TJ, Ruggeri ZM, Quaranta
V. 1995. The activation state of the integrin
aIIbb3
affects outside-in signals leading to cell spreading and focal adhesion kinase
phosphorylation. J.Biol.Chem., 270:18133-18140.
Medline ID =
95355418
- 83.
Ishida F, Gruel Y, Brojer E, Nugent DJ, Kunicki TJ.
1995. Repertoire cloning of a human IgG inhibitor of
aIIbb3
function. The OG idiotype. Mol. Immunol., 32:613-622.
Medline ID =
95371684
- 82.
Kunicki TJ, Honda S, Dawson B, Honda Y, Ruan C
and Aster RH. 1995. The PlA1 alloantigen system is a sensitive
indicator of the structural integrity of the amino-terminal domain of the
human integrin b3
subunit. Blood Cells, Molecules and Diseases. 21:131-141.
Medline ID =
96113694
- 81.
Honda S, Honda Y, Bauer B, Ruan C and Kunicki TJ.
1995. The impact of three-dimensional structure on the expression of PlA
alloantigens on human integrin
b3.
Blood, 86:234-242.
Medline ID =
95315542
- 80.
Honda S, Tomiyama Y, Pelletier AJ, Annis DS, Honda Y, Orchekowski R, Ruggeri Z
and Kunicki TJ. 1995. Topography of
ligand-induced binding sites (LIBS), including a novel cation-sensitive
epitope (AP5) at the amino-terminus, of the human integrin
b3
subunit. J.Biol.Chem., 270:11947-11954.
Medline ID =
95263541
- 79.
Kodandapani R, Veerapandian B, Kunicki TJ, Ely
KR. 1995. Crystal structure of the OP-G2 Fab: An anti-receptor antibody that
mimics an RGD cell adhesion site. In J. Biol. Chem., 270:2268-2273.
Medline ID =
95138198
Index